WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Sees Significant Decrease in Short Interest

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a large decrease in short interest in the month of March. As of March 13th, there was short interest totaling 19,369 shares, a decrease of 85.8% from the February 26th total of 136,094 shares. Based on an average trading volume of 102,267 shares, the short-interest ratio is presently 0.2 days. Based on an average trading volume of 102,267 shares, the short-interest ratio is presently 0.2 days.

WuXi Biologics (Cayman) Trading Up 4.2%

WuXi Biologics (Cayman) stock opened at $8.91 on Wednesday. WuXi Biologics has a 12-month low of $4.14 and a 12-month high of $11.21. The firm has a 50 day simple moving average of $9.67 and a 200-day simple moving average of $9.30.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.